TABLE 2.
Significant Kendall's R between markers of inflammation and RBC fatty acids in hypertriglyceridemic men taking DHA supplements1
| Variable | WBC | Neutrophils | CRP | SAA | MMP-2 | NO |
|---|---|---|---|---|---|---|
| R (P-value) | ||||||
| 17:0 | −0.20 (0.022) | −0.26 (0.005) | −0.21 (0.015) | |||
| 18:0 | −0.21 (0.018) | |||||
| 18:1(n-9) | −0.33 (0.0001) | −0.34 (0.0002) | ||||
| 18:2(n-6) | −0.18 (0.05) | |||||
| 20:0 | −0.19 (0.04) | |||||
| 20:1(n-9) | −0.18 (0.04) | |||||
| 20:2(n-6) | 0.21 (0.02) | −0.22 (0.01) | ||||
| 20:3(n-9) | −0.24 (0.02) | |||||
| 20:3(n-6) | 0.21 (0.01) | |||||
| 20:4(n-6) | 0.19 (0.03) | |||||
| 20:5(n-3) | −0.19 (0.03) | |||||
| 22:0 | −0.23 (0.009) | |||||
| 22:6(n-3) | −0.19 (0.03) | |||||
| 24:0 | −0.22 (0.01) | |||||
| 24:1(n-9) | −0.23 (0.01) | |||||
| Total SFA | 0.18 (0.03) | 0.31 (0.0008) | −0.18 (0.04) | |||
| Total MUFA | −0.28 (0.002) | −0.32 (0.0005) | ||||
| Total (n-6) PUFA | ||||||
| Total (n-3) PUFA | −0.22 (0.01) | |||||
| EPA:AA ratio | −0.21 (0.02) | |||||
| (n-3):(n-6) PUFA ratio | −0.20 (0.02) | |||||
1
R were calculated between inflammatory markers and RBC fatty acid composition using 3 values (study d 0, 45, and 91) from each participant, n = 17.